EGCG binding to membrane receptors, such as TGFR-II, intracellular molecules, such as Pin1 and secreted enzymes, such as MMPs, provided noteworthy information about the mechanisms of EGCG-mediated tumour suppression. This evidence concerns the gene PIN1 and neoplasm.